Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Kenneth Nilsson

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Physiology

Chemicals & Drugs

Disorders

Phenomena

Northern Blotting

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
27
Oberg, Fredrik
21
Nilsson, Gunnar
18
Larsson, Lars-Gunnar
17
Jernberg-Wiklund, Helena
15
Nygren, Peter
15
Sundström, Christer
14
Larsson, Rolf
11
Botling, Johan
8
Bergh, Jonas
8
Hellman, Lars
8
Siegbahn, Agneta
7
Söderberg, Ola
7
Schena, Marina
7
Dimberg, Anna
6
Caligaris-Cappio, Federico

Sign-in to see all Coauthors

Publications

TOP 3
Nilsson K
Septicaemia with Rickettsia helvetica in a patient with acute febrile illness, rash and myasthenia.
Tshuikina Marina; Jernberg-Wiklund Helena; Nilsson Kenneth; Oberg Fredrik
Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma.
Tshuikina Marina; Nilsson Kenneth; Oberg Fredrik
Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Kenneth Nilsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Nilsson K
Septicaemia with Rickettsia helvetica in a patient with acute febrile illness, rash and myasthenia.
The Journal of infection 2009;58(1):79-82.
2008: Tshuikina Marina; Jernberg-Wiklund Helena; Nilsson Kenneth; Oberg Fredrik
Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma.
Experimental hematology 2008;36(12):1673-1681.
2008: Tshuikina Marina; Nilsson Kenneth; Oberg Fredrik
Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene.
Gene 2008;410(2):259-67.
2007: Menu Eline; Jernberg-Wiklund Helena; De Raeve Hendrik; De Leenheer Evy; Coulton Les; Gallagher Orla; Van Valckenborgh Els; Larsson Olle; Axelson Magnus; Nilsson Kenneth; Van Camp Ben; Croucher Peter; Vanderkerken Karin
Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: beneficial effects on tumor growth, angiogenesis, bone disease and survival.
International journal of cancer. Journal international du cancer 2007;121(8):1857-61.
2007: Kårehed Karin; Dimberg Anna; Dahl Staffan; Nilsson Kenneth; Oberg Fredrik
IFN-gamma-induced upregulation of Fcgamma-receptor-I during activation of monocytic cells requires the PKR and NFkappaB pathways.
Molecular immunology 2007;44(4):615-24.
2007: Jernberg-Wiklund Helena; Nilsson Kenneth
Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Advances in cancer research 2007;97():139-65.
2006: Dimberg A; Kårehed K; Nilsson K; Oberg F
Inhibition of monocytic differentiation by phosphorylation-deficient Stat1 is associated with impaired expression of Stat2, ICSBP/IRF8 and C/EBPepsilon.
Scandinavian journal of immunology 2006;64(3):271-9.
2006: Skogsberg S; Tobin G; Kröber A; Kienle D; Thunberg U; Aleskog A; Karlsson K; Laurell A; Merup M; Vilpo J; Sundström C; Roos G; Jernberg-Wiklund H; Döhner H; Nilsson K; Stilgenbauer S; Rosenquist R
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(1):77-81.
2006: Strömberg Thomas; Ekman Simon; Girnita Leonard; Dimberg Lina Y; Larsson Olle; Axelson Magnus; Lennartsson Johan; Hellman Ulf; Carlson Kristina; Osterborg Anders; Vanderkerken Karin; Nilsson Kenneth; Jernberg-Wiklund Helena
IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.
Blood 2006;107(2):669-78.
2006: Menu Eline; Jernberg-Wiklund Helena; Stromberg Thomas; De Raeve Hendrik; Girnita Leonard; Larsson Olle; Axelson Magnus; Asosingh Kewal; Nilsson Kenneth; Van Camp Ben; Vanderkerken Karin
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model.
Blood 2006;107(2):655-60.
2005: Dimberg Lina Y; Dimberg Anna I; Ivarsson Karolina; Strömberg Thomas; Osterborg Anders; Nilsson Kenneth; Oberg Fredrik; Jernberg Wiklund Helena
Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells.
Blood 2005;106(4):1346-54.
2005: Tobin G; Skogsberg A; Thunberg U; Laurell A; Aleskog A; Merup M; Sundström C; Roos G; Nilsson K; Rosenquist R
Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(5):871-3.
2005: Nilsson Kenneth; Lukinius Agneta; Påhlson Carl; Moron Cecilia; Hajem Neda'a; Olsson Britt; Lindquist Olle
Evidence of Rickettsia spp. infection in Sweden: a clinical, ultrastructural and serological study.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2005;113(2):126-34.
2005: Nilsson K; Liu A; Påhlson C; Lindquist O
Demonstration of intracellular microorganisms (Rickettsia spp., Chlamydia pneumoniae, Bartonella spp.) in pathological human aortic valves by PCR.
The Journal of infection 2005;50(1):46-52.
2004: Aleskog Anna; Tobin Gerard; Laurell Anna; Thunberg Ulf; Lindhagen Elin; Roos Göran; Nilsson Kenneth; Nygren Peter; Sundström Christer; Höglund Martin; Larsson Rolf; Rosenquist Richard
VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.
European journal of haematology 2004;73(6):407-11.
2004: Nilsson Joacim; Söderberg Ola; Nilsson Kenneth; Rosén Anders
Differentiation-associated redox-regulation in human B cell lines from stem cell/pro-B to plasma cell.
Immunology letters 2004;94(1-2):83-9.
2004: Strömberg Thomas; Dimberg Anna; Hammarberg Anna; Carlson Kristina; Osterborg Anders; Nilsson Kenneth; Jernberg-Wiklund Helena
Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone.
Blood 2004;103(8):3138-47.
2004: Hovstadius Peter; Lindhagen Elin; Hassan Sadia; Nilsson Kenneth; Jernberg-Wiklund Helena; Nygren Peter; Binderup Lise; Larsson Rolf
Cytotoxic effect in vivo and in vitro of CHS 828 on human myeloma cell lines.
Anti-cancer drugs 2004;15(1):63-70.
2004: Gullbo Joachim; Lövborg Henrik; Dhar Sumeer; Lukinius Agneta; Oberg Fredrik; Nilsson Kenneth; Björkling Fredrik; Binderup Lise; Nygren Peter; Larsson Rolf
Development and characterization of two human tumor sublines expressing high-grade resistance to the cyanoguanidine CHS 828.
Anti-cancer drugs 2004;15(1):45-54.
2003: Tenno Taavo; Oberg Fredrik; Mackman Nigel; Nilsson Kenneth; Siegbahn Agneta
PML/RARalpha plays a role for basal activity and retinoid-induced repression of the tissue factor promoter in acute promyelocytic leukemia cells.
Thrombosis and haemostasis 2003;90(5):930-9.
2003: Fischer Marie; Juremalm Mikael; Olsson Niclas; Backlin Carin; Sundström Christer; Nilsson Kenneth; Enblad Gunilla; Nilsson Gunnar
Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue.
International journal of cancer. Journal international du cancer 2003;107(2):197-201.
2003: Dimberg Anna; Karlberg Inger; Nilsson Kenneth; Oberg Fredrik
Ser727/Tyr701-phosphorylated Stat1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells.
Blood 2003;102(1):254-61.
2003: Hjertson Malin; Kivinen Petri K; Dimberg Lina; Nilsson Kenneth; Harvima Ilkka T; Nilsson Gunnar
Retinoic acid inhibits in vitro development of mast cells but has no marked effect on mature human skin tryptase- and chymase-positive mast cells.
The Journal of investigative dermatology 2003;120(2):239-45.
2003: Möller C; Strömberg T; Juremalm M; Nilsson K; Nilsson G
Expression and function of chemokine receptors in human multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(1):203-10.
2003: Sundström Magnus; Vliagoftis Harissios; Karlberg Peter; Butterfield Joseph H; Nilsson Kenneth; Metcalfe Dean D; Nilsson Gunnar
Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene.
Immunology 2003;108(1):89-97.
2002: Spets Helena; Strömberg Thomas; Georgii-Hemming Patrik; Siljason Jan; Nilsson Kenneth; Jernberg-Wiklund Helena
Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: regulation during interleukin-6(IL-6)-induced growth and survival.
European journal of haematology 2002;69(2):76-89.
2002: Nilsson Kenneth; Påhlson Carl; Lukinius Agneta; Eriksson Lars; Nilsson Lennart; Lindquist Olle
Presence of Rickettsia helvetica in granulomatous tissue from patients with sarcoidosis.
The Journal of infectious diseases 2002;185(8):1128-38.
2002: Dimberg Anna; Bahram Fuad; Karlberg Inger; Larsson Lars-Gunnar; Nilsson Kenneth; Oberg Fredrik
Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1).
Blood 2002;99(6):2199-206.
2001: Guzhova I; Hultquist A; Cetinkaya C; Nilsson K; Påhlman S; Larsson L G
Interferon-gamma cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells.
International journal of cancer. Journal international du cancer 2001;94(1):97-108.
2001: Molin D; Fischer M; Xiang Z; Larsson U; Harvima I; Venge P; Nilsson K; Sundström C; Enblad G; Nilsson G
Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
British journal of haematology 2001;114(3):616-23.
2001: Oberg F; Wu S; Bahram F; Nilsson K; Larsson L G
Cytokine-induced restoration of differentiation and cell cycle arrest in v-Myc transformed U-937 monoblasts correlates with reduced Myc activity.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(2):217-27.
2000: Juremalm M; Hjertson M; Olsson N; Harvima I; Nilsson K; Nilsson G
The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin.
European journal of immunology 2000;30(12):3614-22.
2000: Dimberg A; Nilsson K; Oberg F
Phosphorylation-deficient Stat1 inhibits retinoic acid-induced differentiation and cell cycle arrest in U-937 monoblasts.
Blood 2000;96(8):2870-8.
2000: Tenno T; Botling J; Oberg F; Jossan S; Nilsson K; Siegbahn A
The role of RAR and RXR activation in retinoid-induced tissue factor suppression.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(6):1105-11.
2000: Dhar S; Gullbo J; Csoka K; Eriksson E; Nilsson K; Nickel P; Larsson R; Nygren P
Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients.
European journal of cancer (Oxford, England : 1990) 2000;36(6):803-9.
2000: Pettersson M; Dannaeus K; Nilsson K; Jönsson J I
Isolation of MYADM, a novel hematopoietic-associated marker gene expressed in multipotent progenitor cells and up-regulated during myeloid differentiation.
Journal of leukocyte biology 2000;67(3):423-31.
2000: Nilsson J; Söderberg O; Nilsson K; Rosén A
Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells.
Blood 2000;95(4):1420-6.
1999: Dannaeus K; Johannisson A; Nilsson K; Jönsson J I
Flt3 ligand induces the outgrowth of Mac-1+B220+ mouse bone marrow progenitor cells restricted to macrophage differentiation that coexpress early B cell-associated genes.
Experimental hematology 1999;27(11):1646-54.
1999: Söderberg O; Thunberg U; Weigelt C; Christiansen I; Tötterman T H; Carlsson M; Sällström J; Nilsson K
Staphylococcus aureus Cowan strain 1 activation of B-chronic lymphocytic leukaemia cells augments the response to CD40 stimulation.
Scandinavian journal of immunology 1999;50(4):363-70.
1999: Nilsson K; Lindquist O; Påhlson C
Association of Rickettsia helvetica with chronic perimyocarditis in sudden cardiac death.
Lancet 1999;354(9185):1169-73.
1999: Tenno T; Oberg F; Nilsson K; Siegbahn A
Induction of differentiation in U-937 and NB4 cells is associated with inhibition of tissue factor production.
European journal of haematology 1999;63(2):112-9.
1999: Hjertson M; Sundström C; Nilsson K; Nilsson G
The potential of human mast cell progenitors to differentiate into mature mast cells remains after prolonged culture with flt3 ligand, interleukin-3 or granulocyte-macrophage colony stimulating factor.
British journal of haematology 1999;104(3):516-22.
1999: Georgii-Hemming P; Strömberg T; Janson E T; Stridsberg M; Wiklund H J; Nilsson K
The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-6)-dependent and IL-6-independent human multiple myeloma cell lines.
Blood 1999;93(5):1724-31.
1999: Nilsson K; Lindquist O; Liu A J; Jaenson T G; Friman G; Påhlson C
Rickettsia helvetica in Ixodes ricinus ticks in Sweden.
Journal of clinical microbiology 1999;37(2):400-3.
1999: Nilsson K; Georgii-Hemming P; Spets H; Jernberg-Wiklund H
The control of proliferation, survival and apoptosis in human multiple myeloma cells in vitro.
Current topics in microbiology and immunology 1999;246():325-32; discussion 333.
1998: Spets H; Georgii-Hemming P; Siljason J; Nilsson K; Jernberg-Wiklund H
Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines.
Blood 1998;92(8):2914-23.
1998: Nilsson G; Hjertson M; Andersson M; Greiff L; Svensson C; Nilsson K; Siegbahn A
Demonstration of mast-cell chemotactic activity in nasal lavage fluid: characterization of one chemotaxin as c-kit ligand, stem cell factor.
Allergy 1998;53(9):874-9.
1998: Dannaeus K; Nilsson K; Jönsson J I
Distinct actions of Flt3 ligand and stem cell factor on myeloid lineage selection and maturation of granulocytes versus macrophages.
Experimental hematology 1998;26(4):345-52.
1997: Tenno T; Botling J; Oberg F; Nilsson K; Siegbahn A
Tissue factor expression in human monocytic cell lines.
Thrombosis research 1997;88(2):215-28.
1997: Söderberg O; Christiansen I; Nilsson G; Carlsson M; Nilsson K
Interleukin-15 + thioredoxin induce DNA synthesis in B-chronic lymphocytic leukemia cells but not in normal B cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(8):1298-304.
1997: Spets H; Jernberg-Wiklund H; Sambade C; Söderberg O; Nilsson K
The effects on growth and survival of IL-6 can be dissociated in the U-266-1970/U-266-1984 and HL407E/HL407L human multiple myeloma cell lines.
British journal of haematology 1997;98(1):126-33.
1997: Söderberg O; Christiansen I; Carlsson M; Nilsson K
CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells.
Scandinavian journal of immunology 1997;45(6):706-14.
1997: Johansson M W; Patarroyo M; Oberg F; Siegbahn A; Nilsson K
Myeloperoxidase mediates cell adhesion via the alpha M beta 2 integrin (Mac-1, CD11b/CD18).
Journal of cell science 1997;110 ( Pt 9)():1133-9.
1997: Larsson E; Venables P; Andersson A C; Fan W; Rigby S; Botling J; Oberg F; Cohen M; Nilsson K
Tissue and differentiation specific expression on the endogenous retrovirus ERV3 (HERV-R) in normal human tissues and during induced monocytic differentiation in the U-937 cell line.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 3():142-4.
1997: Botling J; Castro D S; Oberg F; Nilsson K; Perlmann T
Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation.
The Journal of biological chemistry 1997;272(14):9443-9.
1997: Nilsson K; Jaenson T G; Uhnoo I; Lindquist O; Pettersson B; Uhlén M; Friman G; Påhlson C
Characterization of a spotted fever group Rickettsia from Ixodes ricinus ticks in Sweden.
Journal of clinical microbiology 1997;35(1):243-7.
1997: Larsson L G; Bahram F; Wu S; Oberg F; Nilsson K; Lüscher B
Cytokine-induced inhibition of Myc activity in monocytic cells.
Current topics in microbiology and immunology 1997;224():191-200.
1997: Jönsson J I; Nilsson K; Phillips R A
Concentration-dependent effects of hematopoietic growth factors during in vitro expansion of mouse stem cells and progenitor cells.
Growth factors (Chur, Switzerland) 1997;14(1):59-66.
1996: Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1996;7(9):1239-49.
1996: Dhar S; Nygren P; Csoka K; Botling J; Nilsson K; Larsson R
Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance.
British journal of cancer 1996;74(6):888-96.
1996: Georgii-Hemming P; Wiklund H J; Ljunggren O; Nilsson K
Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines.
Blood 1996;88(6):2250-8.
1996: Forsberg-Nilsson K; Dunder U; Nilsson K; Schwartz L B; Nilsson G
The fibroblast mitogenic activity released from human basophilic cell line KU812 is separate from tryptase and PDGF expression.
Scandinavian journal of immunology 1996;44(3):267-72.
1996: Nilsson G; Johnell M; Hammer C H; Tiffany H L; Nilsson K; Metcalfe D D; Siegbahn A; Murphy P M
C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(4):1693-8.
1996: Ridefelt P; Larsson R; Nygren P; Larsson E; Nilsson K
Modulation of calcium signalling and proliferation in monoblastoid U-937 cells.
Anticancer research 1996;16(4A):1643-50.
1996: Larsson E; Venables P J; Andersson A C; Fan W; Rigby S; Botling J; Oberg F; Cohen M; Nilsson K
Expression of the endogenous retrovirus ERV3 (HERV-R) during induced monocytic differentiation in the U-937 cell line.
International journal of cancer. Journal international du cancer 1996;67(3):451-6.
1996: Blom T; Nilsson G; Sundström C; Nilsson K; Hellman L
Characterization of a human basophil-like cell line (LAMA-84).
Scandinavian journal of immunology 1996;44(1):54-61.
1996: Nilsson G; Blom T; Harvima I; Kusche-Gullberg M; Nilsson K; Hellman L
Stem cell factor-dependent human cord blood derived mast cells express alpha- and beta-tryptase, heparin and chondroitin sulphate.
Immunology 1996;88(2):308-14.
1996: Hjertson M; Sundström C; Lyman S D; Nilsson K; Nilsson G
Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells.
Experimental hematology 1996;24(6):748-54.
1995: Botling J; Oberg F; Nilsson K
CD49f (alpha 6 integrin) and CD66a (BGP) are specifically induced by retinoids during human monocytic differentiation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(12):2034-41.
1995: Pettersson M; Sundström C; Nilsson K; Larsson L G
The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines.
Blood 1995;86(7):2747-53.
1995: Liminga G; Nygren P; Dhar S; Nilsson K; Larsson R
Cytotoxic effect of calcein acetoxymethyl ester on human tumor cell lines: drug delivery by intracellular trapping.
Anti-cancer drugs 1995;6(4):578-85.
1995: Nilsson G; Svensson V; Nilsson K
Constitutive and inducible cytokine mRNA expression in the human mast cell line HMC-1.
Scandinavian journal of immunology 1995;42(1):76-81.
1995: Nilsson G; Nilsson K
Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4.
European journal of immunology 1995;25(3):870-3.
1994: Nilsson G; Butterfield J H; Nilsson K; Siegbahn A
Stem cell factor is a chemotactic factor for human mast cells.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(8):3717-23.
1994: Abrink M; Gobl A E; Huang R; Nilsson K; Hellman L
Human cell lines U-937, THP-1 and Mono Mac 6 represent relatively immature cells of the monocyte-macrophage cell lineage.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(9):1579-84.
1994: Fridborg H; Jonsson B; Nygren P; Csoka K; Nilsson K; Oberg G; Kristensen J; Bergh J; Tholander B; Olsen L
Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
British journal of cancer 1994;70(1):11-7.
1994: Botling J; Liminga G; Larsson R; Nygren P; Nilsson K
Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170-kDa P-glycoprotein.
International journal of cancer. Journal international du cancer 1994;58(2):269-74.
1994: Nilsson G; Blom T; Kusche-Gullberg M; Kjellén L; Butterfield J H; Sundström C; Nilsson K; Hellman L
Phenotypic characterization of the human mast-cell line HMC-1.
Scandinavian journal of immunology 1994;39(5):489-98.
1994: Nilsson G; Carlsson M; Jones I; Ahlstedt S; Matsson P; Nilsson K
TNF-alpha and IL-6 induce differentiation in the human basophilic leukaemia cell line KU812.
Immunology 1994;81(1):73-8.
1993: Schena M; Gottardi D; Ghia P; Larsson L G; Carlsson M; Nilsson K; Caligaris-Cappio F
The role of Bcl-2 in the pathogenesis of B chronic lymphocytic leukemia.
Leukemia & lymphoma 1993;11(3-4):173-9.
1993: Huang R; Abrink M; Gobl A E; Nilsson G; Aveskogh M; Larsson L G; Nilsson K; Hellman L
Expression of a mast cell tryptase in the human monocytic cell lines U-937 and Mono Mac 6.
Scandinavian journal of immunology 1993;38(4):359-67.
1993: Oberg F; Botling J; Nilsson K
Macrophages and the cytokine network.
Transplantation proceedings 1993;25(2):2044-7.
1993: Carlsson M; Söderberg O; Nilsson K
Interleukin-4 (IL-4) enhances homotypic adhesion of activated B-chronic lymphocytic leukaemia (B-CLL) cells via a selective up-regulation of CD54.
Scandinavian journal of immunology 1993;37(4):515-22.
1993: Oberg F; Botling J; Nilsson K
Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(8 Pt 1):3487-95.
1993: Larsson L G; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(2):226-34.
1992: Larsson R; Jonsson B; Csoka K; Kristensen J; Nilsson K; Nygren P
Selective cytotoxic activity of cyclosporins against tumor cells from patients with B cell chronic lymphocytic leukemia.
European journal of pharmacology 1992;228(4):237-40.
1992: Jonsson B; Nilsson K; Nygren P; Larsson R
SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma.
Anti-cancer drugs 1992;3(6):641-6.
1992: Larsson L G; Oberg F; Stöckbauer P; Masucci M G; Nilsson K
Suppression of basal, PMA- and IFN-alpha-, but not IFN-gamma-induced expression of HLA class I in v-myc-transformed U-937 monoblasts.
International journal of cancer. Journal international du cancer 1992;52(5):759-65.
1992: Blom T; Huang R; Aveskogh M; Nilsson K; Hellman L
Phenotypic characterization of KU812, a cell line identified as an immature human basophilic leukocyte.
European journal of immunology 1992;22(8):2025-32.
1992: Schena M; Larsson L G; Gottardi D; Gaidano G; Carlsson M; Nilsson K; Caligaris-Cappio F
Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.
Blood 1992;79(11):2981-9.
1992: Jernberg-Wiklund H; Pettersson M; Carlsson M; Nilsson K
Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(4):310-8.
1992: Jernberg-Wiklund H; Pettersson M; Larsson L G; Anton R; Nilsson K
Expression of myc-family genes in established human multiple myeloma cell lines: L-myc but not c-myc gene expression in the U-266 myeloma cell line.
International journal of cancer. Journal international du cancer 1992;51(1):116-23.
1992: Nilsson K
Human B-lymphoid cell lines.
Human cell : official journal of Human Cell Research Society 1992;5(1):25-41.
1992: Schena M; Gaidano G; Gottardi D; Malavasi F; Larsson L G; Nilsson K; Caligaris-Cappio F
Molecular investigation of the cytokines produced by normal and malignant B lymphocytes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(2):120-5.
1992: Pettersson M; Jernberg-Wiklund H; Larsson L G; Sundström C; Givol I; Tsujimoto Y; Nilsson K
Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells.
Blood 1992;79(2):495-502.
1992: Oberg F; Hult N; Bjare U; Ivhed I; Kivi S; Bergh J; Larsson L G; Sundström C; Nilsson K
Characterization of a U-937 subline which can be induced to differentiate in serum-free medium.
International journal of cancer. Journal international du cancer 1992;50(1):153-60.
1992: Nilsson K; Larsson L G; Söderberg O; Schena M; Gottardi D; Caligaris-Cappio F; Carlsson M
On the role of endogenously produced TNF-alpha and IL-6 as regulators of growth and differentiation of B-type chronic lymphocytic leukemia cells in vitro.
Current topics in microbiology and immunology 1992;182():271-7.
1992: Oberg F; Nilsson K
Differentiation and activation associated expression of IL-6 and IL-6 receptors in U-937 monocytic cells: relationship to the expression of CD14.
Growth factors (Chur, Switzerland) 1992;7(1):85-96.
1992: Nilsson K; Larsson L G; Carlsson M
Control of growth and differentiation of B-type chronic lymphocytic leukemia cells in vitro.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 3():20S-21S.
1992: Caligaris-Cappio F; Ghia P; Gottardi D; Parvis G; Gregoretti M G; Nilsson K; Schena M
BCL-2 in B-chronic lymphocytic leukemia.
Current topics in microbiology and immunology 1992;182():279-86.
1991: Nilsson G; Jernberg H; Hellman L; Ahlstedt S; Nilsson K
Enhancement of IgE synthesis in the human myeloma cell line U-266 with an IgE binding factor from a human T-cell line.
Scandinavian journal of immunology 1991;34(6):721-6.
1991: Oberg F; Larsson L G; Anton R; Nilsson K
Interferon gamma abrogates the differentiation block in v-myc-expressing U-937 monoblasts.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(13):5567-71.
1991: Jernberg-Wiklund H; Pettersson M; Nilsson K
Recombinant interferon-gamma inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitro.
European journal of haematology 1991;46(4):231-9.
1991: Larsson L G; Schena M; Carlsson M; Sällström J; Nilsson K
Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells.
Blood 1991;77(5):1025-32.
1991: Jernberg H; Pettersson M; Kishimoto T; Nilsson K
Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(3):255-65.
1990: Johansson K; Nilsson K; Leanderson T
Phorbol ester treatment down-regulates immunoglobulin RNA steady-state levels in B type chronic lymphocytic leukemia and non-Hodgkin's lymphoma cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(9):641-5.
1990: Nõu E; Steinholtz L; Bergh J; Nilsson K; Påhlman S
Neuron-specific enolase as a follow-up marker in small cell bronchial carcinoma. A prospective study in an unselected series.
Cancer 1990;65(6):1380-5.
1990: Nilsson K; Jernberg H; Pettersson M
IL-6 as a growth factor for human multiple myeloma cells--a short overview.
Current topics in microbiology and immunology 1990;166():3-12.
1989: Esscher T; Bergh J; Steinholtz L; Nöu E; Nilsson K; Påhlman S
Neuron-specific enolase in small-cell carcinoma of the lung: the value of combined immunocytochemistry and serum determination.
Anticancer research 1989;9(6):1717-20.
1989: Mårtensson I L; Nilsson K; Leanderson T
Transcriptional regulation of immunoglobulin expression in a chronic lymphocytic leukemia cell line.
European journal of immunology 1989;19(9):1625-9.
1989: Carlsson M; Tötterman T H; Rosén A; Nilsson K
Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(8):593-601.
1989: Carlsson M; Sundström C; Bengtsson M; Tötterman T H; Rosén A; Nilsson K
Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
European journal of immunology 1989;19(5):913-21.
1989: Larsson R; Nygren P; Forsbeck K; Gylfe E; Nilsson K
Early ionic events associated with phorbol ester induced differentiation and inhibition of cell growth in hematopoietic tumor cell lines.
Anticancer research 1989;9(1):1-7.
1989: Matsson P; Almlöf I; Nilsson K; Ahlstedt S
Conditioned media from cultured blood cells of atopic individuals can induce differentiation in the human basophilic leukemia cell line KU812.
International archives of allergy and applied immunology 1989;88(1-2):122-5.
1989: Jernberg H; Nilsson G; Ahlstedt S; Nilsson K
Isotype-specific suppression of IgE synthesis in a human myeloma cell line (U-266) by an IgE-binding protein derived from normal human peripheral blood cells.
International archives of allergy and applied immunology 1989;88(1-2):114-5.
1988: Carlsson M; Matsson P; Rosén A; Sundström C; Tötterman T H; Nilsson K
Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(11):734-44.
1988: Sundström C; Nilsson K; Brenning G
IgE-producing low-grade non-Hodgkin lymphoma.
European journal of haematology 1988;41(4):388-95.
1988: Almlöf I; Nilsson K; Johansson V; Akerblom E; Slotte H; Ahlstedt S; Matsson P
Induction of basophilic differentiation in the human basophilic cell line KU812.
Scandinavian journal of immunology 1988;28(3):293-300.
1988: Forsbeck K; Nilsson K; Nygren P; Larsson R; Gylfe E; Skoglund G; Ingelman-Sundberg M
Phorbol-ester-induced stable changes in the regulation of DNA synthesis and intracellular pH are accompanied by altered expression of protein kinase C in the monoblastoid cell line U-937.
International journal of cancer. Journal international du cancer 1988;42(2):284-8.
1988: Skoglund G; Patarroyo M; Forsbeck K; Nilsson K; Ingelman-Sundberg M
Evidence for separate control by phorbol esters of CD18-dependent adhesion and translocation of protein kinase C in U-937 cells.
Cancer research 1988;48(11):3168-72.
1988: Hellman L; Josephson S; Jernberg H; Nilsson K; Pettersson U
Immunoglobulin synthesis in the human myeloma cell line U-266; expression of two immunoglobulin heavy chain isotypes (epsilon and alpha) after long-term cultivation in vitro.
European journal of immunology 1988;18(6):905-10.
1988: Forsbeck K; Nygren P; Larsson R; Nilsson M; Nilsson K; Gylfe E
Cytoplasmic pH is differently regulated in the monoblastic U-937 and erythroleukemic K-562 cell lines.
Experimental cell research 1988;176(1):96-106.
1988: Larsson L G; Ivhed I; Gidlund M; Pettersson U; Vennström B; Nilsson K
Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(8):2638-42.
1988: Söderdahl G; Betsholtz C; Johansson A; Nilsson K; Bergh J
Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small-cell human lung carcinoma lines.
International journal of cancer. Journal international du cancer 1988;41(4):636-41.
1988: Carlsson M; Tötterman T H; Matsson P; Nilsson K
Cell cycle progression of B-chronic lymphocytic leukemia cells induced to differentiate by TPA.
Blood 1988;71(2):415-21.
1988: Bjare U; Lundblad G; Ivhed I; Nilsson K
Glycosidase and phosphatase activities in U-937 and some clones and sublines.
The International journal of biochemistry 1988;20(2):211-6.
1988: Nilsson K; Björkland A; Carlsson M; Larsson L G; Funa K; Tötterman T
Differentiation associated c-myc expression in phorbol ester and lymphokine stimulated B-type chronic lymphocytic leukemia cells.
Current topics in microbiology and immunology 1988;141():172-80.
1988: Bjare U; Lundblad G; Ivhed I; Nilsson K
Patterns of glycosidases in the histiocytic cell line U-937. Effects of agents inducing cell differentiation.
The International journal of biochemistry 1988;20(11):1291-8.
1987: Jernberg H; Zech L; Nilsson K
Cytogenetic studies on human myeloma cell lines.
International journal of cancer. Journal international du cancer 1987;40(6):811-7.
1987: Siegbahn A; Garcia R C; Kishi K; Nilsson K; Venge P
Specific binding of B-CLL cell-derived chemokinetic inhibitory factor (CIF) to human polymorphonuclear leukocytes.
European journal of haematology 1987;39(2):172-9.
1987: Nygren P; Larsson R; Forsbeck K; Nilsson K; Gylfe E
TPA induces cytoplasmic alkalinization in human monoblastic U-937 cells without activation of Na+/H+ exchange.
Experimental cell research 1987;171(1):265-9.
1987: Jernberg H; Nilsson K; Zech L; Lutz D; Nowotny H; Scheirer W
Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996).
Blood 1987;69(6):1605-12.
1987: Asjö B; Ivhed I; Gidlund M; Fuerstenberg S; Fenyö E M; Nilsson K; Wigzell H
Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones.
Virology 1987;157(2):359-65.
1987: Forsbeck K; Hellman L; Danersund A; Totterman T H; Pettersson U; Nilsson K
TPA-induced differentiation of chronic lymphocytic leukemia cells: studies on mu-chain expression.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1987;1(1):38-43.
1987: Larsson L G; Gray H E; Tötterman T; Pettersson U; Nilsson K
Drastically increased expression of MYC and FOS protooncogenes during in vitro differentiation of chronic lymphocytic leukemia cells.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(1):223-7.
1986: Nilsson K; Larsson L G; Carlsson M; Danersund A; Forsbeck K; Hellman L; Tötterman T; Pettersson U
Expression of c-myc and c-fos during phorbol ester induced differentiation of B-type chronic lymphocytic leukemia cells.
Current topics in microbiology and immunology 1986;132():280-9.
1985: Forsbeck K; Nilsson K; Hansson A; Skoglund G; Ingelman-Sundberg M
Phorbol ester-induced alteration of differentiation and proliferation in human hematopoietic tumor cell lines: relationship to the presence and subcellular distribution of protein kinase C.
Cancer research 1985;45(12 Pt 1):6194-9.
1985: Bergh J; Esscher T; Steinholtz L; Nilsson K; Påhlman S
Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers.
American journal of clinical pathology 1985;84(1):1-7.
1985: Esscher T; Steinholtz L; Bergh J; Nöu E; Nilsson K; Påhlman S
Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung.
Thorax 1985;40(2):85-90.
1984: Påhlman S; Esscher T; Bergh J; Steinholtz L; Nöu E; Nilsson K
Neuron-specific enolase as a marker for neuroblastoma and small-cell carcinoma of the lung.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1984;5(2):119-26.
1983: Tötterman T H; Forsbeck K; Nilsson K; Simonsson B; Sundström C; Sällström J
Surface glycoprotein patterns of B type chronic lymphocytic leukaemia cells correlate with the clinical activity of the disease.
Scandinavian journal of haematology 1983;30(1):79-88.
1981: Nilsson K; Forsbeck K; Gidlund M; Sundström C; Tötterman T; Sällström J; Venge P
Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro.
Haematology and blood transfusion 1981;26():215-21.

Sign-in to see more